News | Careers |Contact
Global

AI-enabled Site-Specific Integration Cell Line Development Platform, AlfaCell Was Awarded the Creative Star of Wings

2023-01-12

[香港，2023年1月12日] 近日，由广东省人力资源和社会保障厅、广东省发展和改革委员会、广东省科学技术厅、广东省乡村振兴局、共青团广东省委员会、广东省残疾人联合会共同举办的第五届“中国创翼”创业创新大赛，历时半年后圆满落下帷幕。大湾生物人工智能定点整合细胞株构建平台AlfaCell®经过逐级选拔，最终荣获创翼之星奖。


第五届“中国创翼”创业创新大赛


人工智能定点整合细胞株构建平台AlfaCell®荣获创翼之星奖



本届大赛以“创响新时代、共圆中国梦”为主题，全国报名参赛项目达73274个。大湾生物商务总监Cindy代表参赛，通过区赛、市赛、省赛层层选拔，大湾生物AI赋能生物制药CMC项目——人工智能定点整合细胞株构建平台AlfaCell®脱颖而出，荣获此次大赛创翼之星奖。


大湾生物商务总监Cindy代表参赛



此次创翼之星奖是AlfaCell®平台继第十四届中国深圳创新创业大赛优秀奖、第六届“创客中国”创新创业大赛优胜奖、第十届中国创新大赛生物医药行业优胜奖之后，获得的又一奖项。
Back
Recent News
Great Bay Bio’s AlfaCell Delivers Average Titer Above 6.9 g/L Across Client Projects, with RCB Completed in Just 1.5 Months

Great Bay Bio’s AlfaCell Delivers Average Titer Above 6.9 g/L Across Client Projects, with RCB Completed in Just 1.5 Months

2026-03-27
Great Bay Bio Recognized in the Deloitte Greater Bay Area Technology Fast 40 & Rising Star Program, Receiving Further Authoritative Recognition for AI-Enabled Bioprocess Innovation

Great Bay Bio Recognized in the Deloitte Greater Bay Area Technology Fast 40 & Rising Star Program, Receiving Further Authoritative Recognition for AI-Enabled Bioprocess Innovation

2026-03-26
Great Bay Bio’s CHO-K1 Catalog Medium AlfaMedX- K1 (Growth Factor–Free) Achieves FDA DMF Filing

Great Bay Bio’s CHO-K1 Catalog Medium AlfaMedX- K1 (Growth Factor–Free) Achieves FDA DMF Filing

2026-03-09
Global Bioprocessing Made Simpler and More Efficient
Schedule a Meeting

Schedule a Meeting

I agree to the privacy policy.

Submit
COPYRIGHT 2026 © Great Bay Bio ALL RIGHTS RESERVD.